Insider Transactions Reported by 12 Insiders of AVENUE THERAPEUTICS, INC.

Symbol
ATXI on OTC
Location
Bay Harbor Islands, FL

There are no Buy or Sell transactions made by insiders since 18 Mar 2025

AVENUE THERAPEUTICS, INC. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Fortress Biotech, Inc. 10%+ Owner $290,223 02 Jan 2026
Robert L. Davidow 10%+ Owner $170,772 11 Dec 2023
Lucy Lu President, CEO, Director $104,853 17 Dec 2021
Alexandra MacLean Chief Executive Officer, Director $23,800 23 Sep 2024
Joseph Walter Vazzano Chief Financial Officer $23,206 17 Dec 2021
David Jin Interim PFO and COO $9,100 23 Sep 2024
Jay D. Kranzler Director $1,252 05 Nov 2024
Neil Herskowitz Director $194 02 Dec 2024
InvaGen Pharmaceuticals, Inc. 10%+ Owner 11 Oct 2022
Lindsay A. Rosenwald MD Director 23 Sep 2024
Curtis Gale Oltmans Director 23 Sep 2024
Faith L. Charles Director 23 Sep 2024

Recent Insider Transactions by Companies or Individuals for AVENUE THERAPEUTICS, INC.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Fortress Biotech, Inc. ATXI COMMON STOCK, PAR VALUE $0.0001 Award 33.8% 111,209 439,733 02 Jan 2026 Direct
Fortress Biotech, Inc. ATXI COMMON STOCK, PAR VALUE $0.0001 Award 11.4% 33,724 328,524 31 Mar 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.